Alcon Investor Presentation at The American Academy of Ophthalmology

Made public by

sourced by PitchSend

16 of 36

Creator

Alcon.com logo
Alcon.com

Category

Healthcare

Published

2009

Slides

Transcriptions

#1W3EBEBWAWAW3E3E3 ΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕ WAEAEAWAWAWAWBEBE Alcon Investor Presentation at the American Academy of Ophthalmology October 24, 2009 Alcon On Exhibit 99.1 Alcor#2ΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕ W3W3E3W3W3W3W3W3W3W3W3W3W3W3W3E Safe Harbor Statement This presentation, made on October 24, 2009, includes forward-looking statements based on current expectations and Alcon does not undertake the obligation to update the forward-looking information or statements. These expectations could differ materially from actual results and are subject to a number of uncertainties and risks as detailed in the company's form 20-F filed with the SEC on March 17, 2009. In addition, this presentation may include several financial measures, to assist in better understanding our business, that are not prepared in accordance with generally accepted accounting principles (GAAP). These non-GAAP financial measures will be reconciled at the end of this presentation or in associated public information filed with the SEC. Reports noted above are available on our website at www.alcon.com in the "Investors and Media" section. For further information contact the Alcon Investor Relations Department at (817) 551-8805. Alcon#3ΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕ W3W3E3WBWBWBWBWBWBWBWBWAWBWBEBE Agenda ■ Opening Remarks - Kevin Buehler ■ Discussion of Growth Drivers - Bill Barton Premium IOLS - Surgical Equipment and Disposables - Glaucoma Product Portfolio ■ Question and Answer Session Kevin Buehler, Bill Barton, Rick Croarkin, Sabri Markabi PhD Alcon#4#5ΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕΠΕ W3W3W3WBWBWAWAWBWAW3W3W3W3W3W3E Opening Remarks ■ American Academy of Ophthalmology enables customer focus Enables best practices and education for doctors Allows Alcon to maintain close customer relationships Provides open dialogue to better understand the needs of the future - - - ■ Value of eye care focus and balanced industry leadership Importance of vision for quality of life Clear market leader in ophthalmology Attractive fundamentals and demographics Product, payor and geographic diversity - - - ■ Continue to develop innovative products through R&D Address unmet medical need for eye-related diseases Utilize centers of excellence to bring products to market Alcon#6#7#8#9#10#11#12#13#14#15#16#17#18#19#20#21#22#23#24#25#26#27#28#29#30#31#32#33#34

Download to PowerPoint

Download presentation as an editable powerpoint.

Related

Fiscal 3Q Investor Presentation image

Fiscal 3Q Investor Presentation

Healthcare

FY23 Full-Year Results Presentation image

FY23 Full-Year Results Presentation

Healthcare

Healthcare Network P&L Statement and Expansion Projects image

Healthcare Network P&L Statement and Expansion Projects

Healthcare

Accreditation and Quality Assurance Overview image

Accreditation and Quality Assurance Overview

Healthcare

Investment Highlights image

Investment Highlights

Healthcare

Investor Presentation image

Investor Presentation

Healthcare

IDEAYA Biosciences Interim IDE397 Phase 1 Clinical Data and Q1 2022 Corporate Update image

IDEAYA Biosciences Interim IDE397 Phase 1 Clinical Data and Q1 2022 Corporate Update

Healthcare

BioAtla Investor Presentation Deck image

BioAtla Investor Presentation Deck

Healthcare